These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 27814442)
1. Botulinum Toxin in the Management of Sialorrhoea in Acquired Brain Injury. Carrol A; McGlone B Ir Med J; 2016 Jun; 109(6):425. PubMed ID: 27814442 [TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated. Restivo DA; Panebianco M; Casabona A; Lanza S; Marchese-Ragona R; Patti F; Masiero S; Biondi A; Quartarone A Toxins (Basel); 2018 Jan; 10(2):. PubMed ID: 29382036 [No Abstract] [Full Text] [Related]
3. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands. Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience. Mahadevan M; Gruber M; Bilish D; Edwards K; Davies-Payne D; van der Meer G Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in the management of sialorrhoea: a systematic review. Lim M; Mace A; Nouraei SA; Sandhu G Clin Otolaryngol; 2006 Aug; 31(4):267-72. PubMed ID: 16911641 [TBL] [Abstract][Full Text] [Related]
6. Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience. Martínez-Poles J; Nedkova-Hristova V; Escribano-Paredes JB; García-Madrona S; Natera-Villalba E; Estévez-Fraga C; López-Sendón Moreno JL; Avilés-Olmos I; Sánchez Díaz G; Martínez Castrillo JC; Alonso-Canovas A Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29843420 [TBL] [Abstract][Full Text] [Related]
7. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472 [TBL] [Abstract][Full Text] [Related]
8. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy. Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276 [TBL] [Abstract][Full Text] [Related]
9. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Banerjee KJ; Glasson C; O'Flaherty SJ Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630 [No Abstract] [Full Text] [Related]
11. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Wilken B; Aslami B; Backes H Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707 [TBL] [Abstract][Full Text] [Related]
12. Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence. Molloy L Curr Opin Neurol; 2007 Aug; 20(4):493-8. PubMed ID: 17620887 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin injections for children with excessive drooling. Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177 [TBL] [Abstract][Full Text] [Related]
14. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. Porta M; Gamba M; Bertacchi G; Vaj P J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):538-40. PubMed ID: 11254784 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands]. Carod Artal FJ Neurologia; 2003 Jun; 18(5):280-4. PubMed ID: 12768517 [TBL] [Abstract][Full Text] [Related]
16. [Submandibular gland resection for the management of sialorrhea in paediatric patients with cerebral palsy and unresponsive to type A botullinum toxin. Pilot study]. Hernández-Palestina MS; Cisneros-Lesser JC; Arellano-Saldaña ME; Plascencia-Nieto SE Cir Cir; 2016; 84(6):459-468. PubMed ID: 27221328 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial of botulinum toxin A for treatment of drooling. Lipp A; Trottenberg T; Schink T; Kupsch A; Arnold G Neurology; 2003 Nov; 61(9):1279-81. PubMed ID: 14610139 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for treatment of parkinsonian sialorrhea. Friedman A; Potulska A Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach. Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of botulinum toxin B in the treatment of drooling. George KS; Kiani H; Witherow H Br J Oral Maxillofac Surg; 2013 Dec; 51(8):783-5. PubMed ID: 23962595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]